-
About UsBeijing Northland Biotechnology Co., Ltd. is an innovative biopharmaceutical company specializing in the research, development, production, and sales of gene therapy drugs, recombinant protein drugs, and ophthalmic drugs. -
R&D and ProductsPrimarily dedicated to the research, development, and industrialization of novel bioengineered drugs in areas such as cardiovascular diseases, metabolic disorders, rare diseases, and ophthalmic diseases. -
Investor RelationsGuided by the principle of “Creating Value, Serving Health,” the company is committed to becoming an innovative biopharmaceutical enterprise, contributing to the advancement of China’s pharmaceutical industry and the well-being of humanity.
2016
January 28
NORTHLAND Invited to Attend the China-Korea FTA Investment Forum
June 8
Huonland, the holding subsidiary, has obtained the registration certificate for ophthalmic solution packaging materials.
June 8
The holding subsidiary, Huonland Company, has obtained clinical trial approval for moxifloxacin hydrochloride eye drops.
August 4
NORTHLAND Biopharmaceutical R&D Base Settles in Jinghai, Tianjin
August 9
Huonland, a holding subsidiary, has successfully obtained the approval number for brimonidine tartrate.
August 17
NORTHLAND Selected for Beijing's Biomedical Industry "G20 Project"
September 14
Holding subsidiary Huonland makes its debut at the 21st National Ophthalmology Annual Conference.
October 31st
NORTHLAND was awarded the title of "50 Most Promising Pharmaceutical Companies on the New Third Board in 2016."
November 11
Huonland has partnered with the Institute of Materia Medica, Chinese Academy of Medical Sciences, to establish a joint R&D base for ophthalmic drugs.
November 15th
Huonland, a holding subsidiary, has proudly received the “Drug GMP Certificate.”
Share to:
Friendly Links: Baidu | NORTHLAND
Contact Information
Address: Room A406, Zhongguancun Biomedical Park, No. 5 Kaituo Road, Shangdi, Haidian District, Beijing
Follow Us
Northland is an innovative biopharmaceutical company specializing in the R&D, manufacturing and sales of gene therapy drugs, recombinant protein drugs and ophthalmic medications.
Web site
NL-BIO
NL003
NL005